Search by Drug Name or NDC

    NDC 13845-1201-03 CYCLOSERINE 250 mg/250mg Details

    CYCLOSERINE 250 mg/250mg

    CYCLOSERINE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is CYCLOSERINE.

    Product Information

    NDC 13845-1201
    Product ID 13845-1201_f2a0c59a-f966-50f8-e053-2995a90a9cc1
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name CYCLOSERINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CYCLOSERINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/250mg
    Substance Name CYCLOSERINE
    Labeler Name Parsolex Gmp Center, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA060593
    Listing Certified Through 2024-12-31

    Package

    NDC 13845-1201-03 (13845120103)

    NDC Package Code 13845-1201-3
    Billing NDC 13845120103
    Package 40 CAPSULE in 1 BOTTLE (13845-1201-3) / 250 mg in 1 CAPSULE (13845-1201-1)
    Marketing Start Date 2009-03-01
    NDC Exclude Flag N
    Pricing Information N/A